
EcoSynthetix reported a small per-share loss for the third quarter. Supplemental reports on the company’s release point to a sharp drop in sales and a sizable cash balance.
EcoSynthetix Inc. (TSX: ECO) released results after the market closed on November 3, 2026, for the quarter ended September 30. Calendar data lists earnings per share (EPS) of -C$0.0062, or about -C$0.01. No estimate is available for the quarter, so there’s no basis for calling the result a beat or a miss. Separate, unverified reports say Q3 sales fell 38% year over year to US$3.6 million. For Canadian investors, the key questions are whether lower sales continue and how the company will use its cash to support its commercial plans.
Recent earnings trend
EcoSynthetix Inc
ECO.TO
ECO.TO
EcoSynthetix Inc
Market cap
$107.58M
52W high
$4.66
52W low
$1.26
1W change
+18.06%
Beta
0.58
Analyst Price Targets
Based on analyst covering ECO · as of Sep 17, 2026
Wall Street analysts forecast ECO stock price to rise 358.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$8.39
+358.5% Upside
Current Price
C$1.83
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ECO's historical volatility
30-Day Vol
89.2%
Annualized
90-Day Vol
69.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.53
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.72 | C$1.27 – C$2.35 |
| 60 trading days | C$1.62 | C$1.05 – C$2.51 |
| 90 trading days | C$1.53 | C$0.90 – C$2.61 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-03 | -0.0062 | — | — |
| 2026-06-30 | 2026-07-28 | -0.0101 | — | — |
| 2026-03-31 | 2026-05-07 | -0.0138 | — | — |
| 2025-12-31 | 2026-02-19 | 0.0036 | — | — |
| 2025-09-30 | 2025-11-06 | -0.0021 | — | — |
| 2025-06-30 | 2025-07-29 | 0.0026 | — | — |
Investor takeaway: The reported loss was small per share, but without an estimate, a beat-or-miss comparison isn’t possible. The reported sales decline is the more important operating signal. The reported US$29.4 million in cash and term deposits provides context on the company’s resources, but it doesn’t guarantee future profits. Check the company’s filings and the ECO stock page before drawing conclusions.
US$3.6 million in reported Q3 sales
Supplemental reports put quarterly sales 38% below the year-earlier period, making demand and sales volumes important to watch. Calendar data lists EPS at -C$0.0062, but there’s no estimate for the quarter to show whether that result was above or below expectations.
Bull case
Supplemental reports say EcoSynthetix added a commercial account with a global top-five tissue producer and ended the quarter with US$29.4 million in cash and term deposits. If the new account leads to steady sales, it could help offset weaker volumes. The cash may give the company room to pursue commercial opportunities, but the available information doesn’t show how quickly those efforts could increase revenue or improve margins.
Bear case
The reported 38% year-over-year sales decline is a clear concern. The fundamentals snapshot also shows a -6.31% profit margin and trailing EPS of -C$0.03. The next-quarter outlook is modest: one analyst estimates revenue of US$4.14 million, down 7.4% year over year, and EPS of -C$0.01. Since that estimate comes from one analyst, treat it as a limited indicator, not a broad consensus.
Analysis
EcoSynthetix released its third-quarter results after the market closed on November 3, covering the period ended September 30, 2026. Calendar data lists EPS at -C$0.0062, or about -C$0.01 per share. No estimate is available for the quarter, so there’s no sound basis for calling the result a beat or a miss. The fundamentals snapshot lists trailing EPS of -C$0.03 and a profit margin of -6.31%, indicating the company remains unprofitable on those measures.
Supplemental reports on the company’s release put Q3 sales at US$3.6 million, down 38% year over year amid lower volumes. These details aren’t in the supplied earnings calendar data, so check them against the company’s release and regulatory filings. If accurate, the sales decline matters more than the small per-share loss. It raises questions about demand, customer activity and how quickly new commercial accounts can contribute to revenue.
The same reports say EcoSynthetix ended the quarter with US$29.4 million in cash and term deposits and added a commercial account with a global top-five tissue producer. Both details provide useful context, but neither guarantees a near-term recovery. Follow company filings and updates through the ECO stock page.
Analysis
The next-quarter outlook is based on one analyst, who estimates EPS of -C$0.01 and revenue of US$4.14 million, down 7.4% year over year. The EPS estimate hasn’t changed in 30 days. With only one analyst represented, these figures offer a limited snapshot rather than a reliable consensus. They still point to continued losses and pressure on revenue.
The supplied market data lists a last close of C$1.83, below the 50-day moving average of C$1.84 and the 200-day average of C$2.86. The shares rose 18.06% over one week but fell 4.19% over one month. These figures cover the supplied period and shouldn’t be read as a reaction to the earnings release. The 52-week range was C$1.26 to C$4.66. See the ECO stock overview for more company-specific information.
Analysis
The supplied analyst-target data lists an average target of C$8.39, compared with the last close of C$1.83—a difference of 358.5%. The data labels the consensus bullish based on the average target versus the last close, but a formal rating isn’t available for this Canadian listing. A large gap between a target and the market price doesn’t promise a return. The supplied information also doesn’t say how many analysts contributed to the target. Treat it as an uncertain estimate, not a price floor. See the analyst ratings section for details.
Analysis
Wealth Awesome’s statistical 90-day model, dated November 10, lists a current price of C$1.83 and a 90-day average forecast of C$1.53. Its 68% range is C$0.90 to C$2.61, and its wider 95% range is C$0.53 to C$4.45. The model’s average forecasts are C$1.72 for 30 days, C$1.62 for 60 days and C$1.53 for 90 days. It also reports annualized drift of -50.0% and 30-day volatility of 89.2%.
This statistical model isn’t financial advice and doesn’t guarantee future prices. Its wide ranges and high reported volatility point to substantial uncertainty. Review the price-prediction section alongside company filings and your own risk tolerance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


